DIGITEK RECALL

Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of Digitek® (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.

The Class I Recall of all lots is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than is appropriate.

Digitek® is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure.   OVERDOSE SYMPTOMS:   Death   Low blood pressure   Cardiac instability   Bradycardia   RECALLED MEDICATION LIST:   Digitek   Digoxin   Lanoxin   Cardoxin   Lanoxicaps   MANUFACTURERS: *Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan.   READ OUR PRIVACY POLICY  >>

To contact our office submit your question or comment using the form below or call 516-228-4226. Fields in *Red are required fields.   CONTACT INFORMATION:   Contact name:   Street address:   City:   State:   Zip:   Email:   Note:     Please include Area Code.   Phone:   Cell:      COMMENTS / QUESTIONS: Type your comment or question here.          By clicking here I understand that I am not     entering into an attorney client relationship.